Braidwell LP
- SEC CIK
- 0001920938
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 75
- +5 vs. Q1 2024
- Portfolio value
- $3.19B
- +$85.0M (+2.7%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Guardant Health, Inc.40131MAB5 | NOTE 11/1 | – | $208.1M | 6.5% | – | – | – |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $143.0M | 4.5% | – | – | – |
| NovoCure Ltd67011XAB9 | NOTE 11/0 | – | $129.8M | 4.1% | – | – | – |
| Nuvasive Inc670704AJ4 | NOTE 0.375% 3/1 | – | $110.1M | 3.5% | – | – | – |
| NBIXNeurocrine Biosciences Inc | Stock | 759,009 | $104.5M | 3.3% | +28,800+3.9% | Added | History |
| CGONCG Oncology, Inc. | COM | 3,309,507 | $104.5M | 3.3% | +2,179,272+192.8% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 2,560,573 | $99.8M | 3.1% | +1,252,562+95.8% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 2,392,042 | $94.1M | 3.0% | +549,527+29.8% | Added | History |
| Neogenomics Inc64049MAB6 | NOTE 0.250% 1/1 | – | $90.8M | 2.8% | – | – | – |
| Ironwood Pharmaceuticals Inc46333XAH1 | NOTE 1.500% 6/1 | – | $84.6M | 2.7% | – | – | – |
| Dexcom Inc252131AM9 | NOTE 0.375% 5/1 | – | $81.2M | 2.5% | – | New | – |
| GHGuardant Health, Inc. | COM | 2,807,968 | $81.1M | 2.5% | +331,164+13.4% | Added | History |
| Insulet Corp45784PAK7 | NOTE 0.375% 9/0 | – | $74.4M | 2.3% | – | – | – |
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,669,720 | $74.0M | 2.3% | +425,925+34.2% | Added | History |
| Dexcom Inc252131AK3 | NOTE 0.250%11/1 | – | $73.8M | 2.3% | – | – | – |
| ARGXArgenx SE | SPONSORED ADR | 166,924 | $71.8M | 2.3% | −52,900−24.1% | Reduced | History |
| ALGNAlign Technology Inc | COM | 275,207 | $66.4M | 2.1% | +105,955+62.6% | Added | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 9,024,037 | $64.6M | 2.0% | +1,802,077+25.0% | Added | History |
| PCVXVaxcyte, Inc. | COM | 808,303 | $61.0M | 1.9% | −404,400−33.3% | Reduced | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 2,514,538 | $59.1M | 1.9% | +1,999,538+388.3% | Added | History |
| GKOSGLAUKOS Corp | COM | 496,576 | $58.8M | 1.8% | +45,900+10.2% | Added | History |
| VKTXViking Therapeutics, Inc. | COM | 1,106,905 | $58.7M | 1.8% | +393,805+55.2% | Added | History |
| IRTCiRhythm Holdings, Inc. | COM | 526,357 | $56.7M | 1.8% | +43,100+8.9% | Added | History |
| Alphatec Hldgs Inc02081GAB8 | NOTE 0.750% 8/0 | – | $56.6M | 1.8% | – | – | – |
| Sarepta Therapeutics, Inc.803607AD2 | NOTE 1.250% 9/1 | – | $55.5M | 1.7% | – | – | – |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $52.3M | 1.6% | – | – | – |
| INSPInspire Medical Systems, Inc. | COM | 379,443 | $50.8M | 1.6% | +277,951+273.9% | Added | History |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $48.8M | 1.5% | – | – | – |
| EXASExact Sciences Corp | COM | 1,141,678 | $48.2M | 1.5% | +1,141,678 | New | History |
| KROSKeros Therapeutics, Inc. | COM | 982,209 | $44.9M | 1.4% | +244,830+33.2% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 100,500 | $44.7M | 1.4% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 3,035,904 | $41.8M | 1.3% | +862,200+39.7% | Added | History |
| RGENRepligen Corp | COM | 323,509 | $40.8M | 1.3% | +180,673+126.5% | Added | History |
| AVDLAvadel Pharmaceuticals PLC | Stock | 2,898,639 | $40.8M | 1.3% | +230,090+8.6% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 70,449 | $39.0M | 1.2% | +23,300+49.4% | Added | History |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 2,058,303 | $38.4M | 1.2% | +665,587+47.8% | Added | History |
| PENPenumbra Inc | COM | 212,594 | $38.3M | 1.2% | −83,298−28.2% | Reduced | History |
| KIDSOrthopediatrics Corp | COM | 1,107,770 | $31.9M | 1.0% | 00.0% | Unchanged | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 4,438,232 | $28.9M | 0.9% | +948,389+27.2% | Added | History |
| TMDXTransMedics Group, Inc. | COM | 189,960 | $28.6M | 0.9% | −424,571−69.1% | Reduced | History |
| FNAParagon 28, Inc. | COM | 4,150,109 | $28.4M | 0.9% | +784,500+23.3% | Added | History |
| IMCRImmunocore Holdings plc | ADS | 797,268 | $27.0M | 0.8% | +797,268 | New | History |
| AKROAkero Therapeutics, Inc. | COM | 1,084,400 | $25.4M | 0.8% | +1,084,400 | New | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 611,800 | $23.5M | 0.7% | +611,800 | New | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 2,194,900 | $22.9M | 0.7% | +2,194,900 | New | History |
| LXEOLexeo Therapeutics, Inc. | COM | 1,382,481 | $22.2M | 0.7% | +60,204+4.6% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 107,179 | $19.7M | 0.6% | −69,910−39.5% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 3,006,799 | $19.6M | 0.6% | −737,200−19.7% | Reduced | History |
| NVRONevro Corp | COM | 1,698,768 | $14.3M | 0.4% | −77,600−4.4% | Reduced | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 8,294,950 | $13.9M | 0.4% | +8,294,950 | New | History |
| ARVNArvinas, Inc. | COM | 517,230 | $13.8M | 0.4% | +517,230 | New | History |
| SRPTSarepta Therapeutics, Inc. | COM | 81,900 | $12.9M | 0.4% | +81,900 | New | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,466,610 | $11.8M | 0.4% | +806,588+122.2% | Added | History |
| OCULOcular Therapeutix, Inc | COM | 1,643,770 | $11.2M | 0.4% | +1,643,770 | New | History |
| ALECAlector, Inc. | COM | 2,380,704 | $10.8M | 0.3% | 00.0% | Unchanged | History |
| Haemonetics Corp Mass405024AB6 | NOTE 3/0 | – | $10.4M | 0.3% | – | – | – |
| SKINSkinHealth Systems Inc. | COM CL A | 5,120,685 | $9.83M | 0.3% | +5,120,685 | New | History |
| LIVNLivaNova PLC | SHS | 173,900 | $9.53M | 0.3% | +173,900 | New | History |
| DNTHDianthus Therapeutics, Inc. | COM | 366,851 | $9.49M | 0.3% | +366,851 | New | History |
| REPLReplimune Group, Inc. | COM | 1,013,377 | $9.12M | 0.3% | +1,013,377 | New | History |
| CSTLCastle Biosciences Inc | COM | 416,100 | $9.06M | 0.3% | +416,100 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 345,571 | $8.75M | 0.3% | +744+0.2% | Added | History |
| CELCCelcuity Inc. | COM | 516,643 | $8.46M | 0.3% | +516,643 | New | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 369,458 | $7.75M | 0.2% | −683,027−64.9% | Reduced | History |
| ELEVElevation Acquisition Group Inc. | COM | 2,477,614 | $6.69M | 0.2% | +99,967+4.2% | Added | History |
| HROWHarrow, Inc. | COM | 297,188 | $6.21M | 0.2% | +171,221+135.9% | Added | History |
| LBPHLongboard Pharmaceuticals, Inc. | COM | 205,926 | $5.57M | 0.2% | +205,926 | New | History |
| Cutera Inc232109AD0 | NOTE 2.250% 6/0 | – | $5.05M | 0.2% | – | – | – |
| Cutera Inc232109AG3 | NOTE 4.000% 6/0 | – | $5.03M | 0.2% | – | – | – |
| LUNGPulmonx Corp | COM | 752,541 | $4.77M | 0.1% | 00.0% | Unchanged | History |
| CONMED Corp207410AH4 | NOTE 2.250% 6/1 | – | $4.48M | 0.1% | – | New | – |
| CGEMCullinan Therapeutics, Inc. | COM | 176,173 | $3.07M | 0.1% | −1,064,692−85.8% | Reduced | History |
| OMOutset Medical, Inc. | COM | 694,525 | $2.67M | 0.1% | −1,705,902−71.1% | Reduced | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 2,442,504 | $1.96M | 0.1% | +2,442,504 | New | History |
| ETNB89bio, Inc. | COM | 164,227 | $1.32M | <0.1% | +164,227 | New | History |
Sold out since Q1 2024 (15)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| Exact Sciences Corp30063PAC9 | NOTE 0.375% 3/0 | – | $133.1M | 4.3% | – |
| INSMED Inc457669AA7 | NOTE 1.750% 1/1 | – | $69.4M | 2.2% | – |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $35.8M | 1.2% | – |
| TRMLTourmaline Bio, Inc. | COM | 906,820 | $20.8M | 0.7% | History |
| Ironwood Pharmaceuticals Inc46333XAF5 | NOTE 0.750% 6/1 | – | $19.9M | 0.6% | – |
| BMRNBiomarin Pharmaceutical Inc | COM | 218,896 | $19.1M | 0.6% | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 435,823 | $18.7M | 0.6% | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 3,379,577 | $17.2M | 0.6% | History |
| ITOSiTeos Therapeutics, Inc. | COM | 1,162,374 | $15.9M | 0.5% | History |
| MLYSMineralys Therapeutics, Inc. | COM | 1,147,154 | $14.8M | 0.5% | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 1,300,000 | $12.9M | 0.4% | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 609,643 | $9.59M | 0.3% | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 704,344 | $7.97M | 0.3% | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,843,285 | $5.93M | 0.2% | History |
| ADPTAdaptive Biotechnologies Corp | COM | 1,357,490 | $4.36M | 0.1% | History |